47 results
8-K
TVTX
Travere Therapeutics Inc
4 Dec 23
Cost Associated with Exit or Disposal Activities
4:10pm
quarter of 2024.
As part of the Strategic Reorganization, the Company is implementing an approximate 20% workforce reduction focused on non-field … . The Company expects that the majority of the restructuring charges will be incurred in Q4 2023 and that the implementation of the workforce reduction
8-K
EX-10.1
8uoadch mc4r6snbai
17 Jul 23
Entry into a Material Definitive Agreement
8:07am
8-K
EX-99.1
tuz0m xyldvb6zgce
22 May 23
Departure of Directors or Certain Officers
4:30pm
8-K
EX-99.1
k6q2z
12 May 22
Departure of Directors or Certain Officers
5:26pm
8-K
EX-99.1
0ji2l9 labi2
19 May 21
Departure of Directors or Certain Officers
12:00am